Action of retinoic acid receptor on EGFR gene transactivation and breast cancer cell proliferation: Interplay with the estrogen receptor

Riferimento: 
Biomed Pharmacother. 2011 Jul;65(4):307-12.
Autori: 
Salvatori L, Ravenna L, Caporuscio F, Principessa L, Coroniti G, Frati L, Russo MA, Petrangeli E. luisa.salvatori@ifo.it
Fonte: 
Biomed Pharmacother. 2011 Jul;65(4):307-12.
Anno: 
2011
Azione: 
L'azione dell'acido retinoico (RA) sulla transattivazione del recettore del fattore di crescita epidermico (EGFR) potrebbe essere correlata alla soppressione della crescita RA-mediata osservata nelle cellule tumorali del seno.
Target: 
RA-EGFR/carcinoma mammario.

ABSTRACT
In the present report, we investigated the action of retinoic acid (RA) on the transactivation of the epidermal growth factor receptor (EGFR) gene promoter. In a previous study, we showed that the estrogen receptor (ER) α activated by 17β-estradiol (E₂) increased EGFR expression by enhancing the binding of the transcription factor Sp1 to the EGFR minimal promoter in HeLa cells. Here, we demonstrate that ligand-activated RA receptor (RAR) α inhibited EGFR transactivation by competing with Sp1 for binding to the same promoter fragment in the same cell model. When RARα and ERα were coexpressed, the inhibitory effect of RA on transactivation of the EGFR promoter counteracted the enhancement induced by E₂-activated ERα and became more pronounced in the presence of ligand-free ERα. In the MCF7 breast cancer cell line, which endogenously expresses RARα and ERα, RA exerted anti-proliferative effects in the presence of ligand-free ERα. Moreover, interplay between the pathways mediated by the two receptors was observed, as RA counteracted E₂-induced cell proliferation. Our results suggest that the interference with the activity of Sp1 on the EGFR promoter could be related to the observed RA-mediated growth suppression of breast cancer cells.

Sostanze: